AIL
VIR icon

AGF Investments LLC’s Vir Biotechnology VIR Stock Holding History

AGF Investments LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.33M Buy
69,046
+28,648
+71% +$728K 0.12% 215
2022
Q2 		$1.03M Buy
40,398
+11,241
+39% +$262K 0.1% 49
2022
Q1 		$750K Buy
29,157
+3,670
+14% +$109K 0.06% 217
2021
Q4 		$1.07M Buy
25,487
+13,303
+109% +$521K 0.09% 42
2021
Q3 		$530K Sell
12,184
-1,367
-10% -$59.2K 0.05% 229
2021
Q2 		$641K Buy
13,551
+3,569
+36% +$162K 0.07% 105
2021
Q1 		$512K Sell
9,982
-18,832
-65% -$1.01M 0.06% 228
2020
Q4 		$772K Buy
+28,814
New +$937K 0.09% 175

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AGF Investments LLC's VIR Position: Q3 2022 in Review

AGF Investments LLC increased its Vir Biotechnology (VIR) stake by 71% in Q3 2022, buying an estimated $728K and bringing the position to 69,046 shares worth $1.33M. The position accounts for 0.12% of the portfolio, ranked #215.

AGF Investments LLC first reported a position in VIR in Q4 2020 and has held it in 8 quarters since. 220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

  • AGF Investments LLC held 69,046 shares of Vir Biotechnology worth $1.33M as of Q3 2022.
  • AGF Investments LLC bought 28,648 Vir Biotechnology shares in Q3 2022, an estimated $728K.
  • Vir Biotechnology made up 0.12% of AGF Investments LLC's portfolio in Q3 2022, its #215 holding.
  • AGF Investments LLC first reported a position in Vir Biotechnology in Q4 2020 and has held it in 8 quarters since.
  • 220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.